Palomino Laboratories (PALX) Shares Outstanding (Weighted Average) (2022 - 2025)

Palomino Laboratories has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $8.8 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $8.8 million, up 475.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.8 million (up 475.38% YoY), and the FY2025 annual result was $8.8 million, up 475.38% from the prior year.
• Shares Outstanding (Weighted Average) came in at $8.8 million for Q4 2025 at Palomino Laboratories, up from $7.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $8.8 million in Q4 2025 to a low of $1.5 million in Q4 2024.
• The 4-year median for Shares Outstanding (Weighted Average) is $5.0 million (2022), against an average of $4.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 69.53% in 2024 and jumped 475.38% in 2025, its largest moves.
• Palomino Laboratories' Shares Outstanding (Weighted Average) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then tumbled by 69.53% to $1.5 million in 2024, then surged by 475.38% to $8.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $8.8 million (Q4 2025), $7.5 million (Q3 2025), and $5.0 million (Q2 2025), per Business Quant data.